Background illustration for clinical trials search

Paid Clinical Trials Naperville

Discover 2,409 paid clinical trials in Naperville, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

for
Solid Tumours
Location: Arlington Heights IL, Indianapolis IN, Maumee OH,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06581432

Phase 2, Recruiting

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

for
Metastatic Prostate Cancer
Location: Arlington Heights IL, Lake Barrington IL, Detroit MI,
Sponsor: ORIC Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT05413421

Phase 1, Recruiting

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

for
Breast Cancer
Location: Arlington Heights IL, Chicago IL, Dyer IN, Milwaukee WI,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06492616

Phase 3, Recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

for
Triple-Negative Breast Cancer
Location: Arlington Heights IL, Skokie IL, Dyer IN, Madison WI,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06393374

Phase 3, Recruiting

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

for
Colorectal Neoplasms
Location: Arlington Heights IL, Peoria IL, Madison WI,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06662786

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

for
Colorectal Neoplasms
Location: Arlington Heights IL, Milwaukee WI, Peoria IL,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06750094

Phase 3, Recruiting

A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

for
Metastatic Colorectal Cancer
Location: Arlington Heights IL, Peoria IL, Springfield IL,
Sponsor: EMD Serono Research & Development Institute, Inc.

Sex: All

Age: 18+

Code: NCT07549412

Phase 3, Recruiting

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

for
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma,
Location: Arlington Heights IL, Chicago IL, Niles IL, Ottawa IL,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07392892

Phase 2, Phase 3, Recruiting

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

for
Carcinoma, Non-Small-Cell Lung
Location: Arlington Heights IL, Chicago IL, Dyer IN,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT06875310

Phase 3, Recruiting

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

for
Ovarian Neoplasms, Ovarian Cancer
Location: Arlington Heights IL, Fort Wayne IN, Indianapolis IN,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT07318558

Phase 3, Recruiting

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

for
Ovarian Neoplasms, Fallopian Tube Neoplasms,
Location: Arlington Heights IL, Chicago IL, Peoria IL, Madison WI,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07213804

Phase 3, Recruiting

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

for
Non-Small-Cell Lung Cancer,
Location: Arlington Heights IL, Chicago IL, Detroit MI,
Sponsor: ArriVent BioPharma, Inc.

Sex: All

Age: 18+

Code: NCT07185997

Phase 3, Recruiting

A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)

for
Colon Cancer, Rectal Cancer, Colorectal Cancer,
Location: Arlington Heights IL, Columbia MO, Maple Grove MN,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 18+

Code: NCT07011576

Phase 2, Recruiting

A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer

for
Prostate Cancer, Prostate Adenocarcinoma
Location: Chicago IL, Dallas TX, Portland OR
Sponsor: University of Chicago

Sex: Male

Age: 18+

Code: NCT05726292

Phase 2, Recruiting

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

for
Heart Failure
Location: Park Ridge IL, Hazel Crest IL, Munster IN,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06935370

Phase 3, Recruiting

AnovaOS Network Powered Patient Registry

for
Infectious Disease, Neoplasms,
Location: Arlington Heights IL
Sponsor: Anova Enterprises, Inc

Sex: All

Age: 18+

Code: NCT05013944

Recruiting

A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease

for
Proteinuric Kidney Disease
Location: Chicago IL, Evanston IL, Saint Joseph MI, Flint MI,
Sponsor: Maze Therapeutics

Sex: All

Age: 18 - 68

Code: NCT06830629

Phase 2, Recruiting

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort

for
Chronic Kidney Disease
Location: Chicago IL, Saint Paul MN, San Antonio TX, Glendale CA
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07024823

Phase 1, Recruiting

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate,
Location: Des Plaines IL, Wyoming MI, Springfield IL, St Louis MO,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07415044

Phase 2, Recruiting
New

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis (UC), Severe Ulcerative Colitis,
Location: Des Plaines IL, Glenview IL, Gurnee IL, Dayton OH,
Sponsor: Palisade Bio

Sex: All

Age: 18 - 70+

Code: NCT07845487

Phase 2, Recruiting